Dr. Hönle AG
Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipme… Read more
Dr. Hönle AG (DRHNF) - Net Assets
Latest net assets as of September 2025: $77.03 Million USD
Based on the latest financial reports, Dr. Hönle AG (DRHNF) has net assets worth $77.03 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($145.52 Million) and total liabilities ($68.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $77.03 Million |
| % of Total Assets | 52.94% |
| Annual Growth Rate | 2.5% |
| 5-Year Change | -30.68% |
| 10-Year Change | N/A |
| Growth Volatility | 14.95 |
Dr. Hönle AG - Net Assets Trend (2016–2025)
This chart illustrates how Dr. Hönle AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dr. Hönle AG (2016–2025)
The table below shows the annual net assets of Dr. Hönle AG from 2016 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $77.03 Million | -3.33% |
| 2024-09-30 | $79.69 Million | -17.11% |
| 2023-09-30 | $96.13 Million | -10.36% |
| 2022-09-30 | $107.24 Million | -3.50% |
| 2021-09-30 | $111.12 Million | -4.77% |
| 2020-09-30 | $116.69 Million | +29.47% |
| 2019-09-30 | $90.12 Million | +3.29% |
| 2018-09-30 | $87.25 Million | +25.04% |
| 2017-09-30 | $69.78 Million | +13.15% |
| 2016-09-30 | $61.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dr. Hönle AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 25.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $28.83 Million | 37.51% |
| Other Components | $48.03 Million | 62.49% |
| Total Equity | $76.87 Million | 100.00% |
Dr. Hönle AG Competitors by Market Cap
The table below lists competitors of Dr. Hönle AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Security
SN:SECURITY
|
$233.46 Million |
|
Dear U Co. Ltd.
KQ:376300
|
$233.50 Million |
|
CNlight Co Ltd
SHE:002076
|
$233.57 Million |
|
HUANLEJIA Food Group Co. Ltd.
SHE:300997
|
$233.60 Million |
|
thyssenkrupp nucera AG & Co. KGaA
OTCGREY:THYKF
|
$233.44 Million |
|
Hyliion Holdings Corp.
NYSE MKT:HYLN
|
$233.40 Million |
|
Rainbow Tours SA
WAR:RBW
|
$233.30 Million |
|
Hunan Hansen Pharmaceutical Co Ltd
SHE:002412
|
$233.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dr. Hönle AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 79,420,000 to 76,867,000, a change of -2,553,000 (-3.2%).
- Net loss of 3,168,000 reduced equity.
- Dividend payments of 128,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.17 Million | -4.12% |
| Dividends Paid | $128.00K | -0.17% |
| Other Changes | $743.00K | +0.97% |
| Total Change | $- | -3.21% |
Book Value vs Market Value Analysis
This analysis compares Dr. Hönle AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.07x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.69x to 4.07x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-09-30 | $19.19 | $51.60 | x |
| 2021-09-30 | $18.26 | $51.60 | x |
| 2022-09-30 | $17.63 | $51.60 | x |
| 2023-09-30 | $15.81 | $51.60 | x |
| 2024-09-30 | $13.10 | $51.60 | x |
| 2025-09-30 | $12.68 | $51.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dr. Hönle AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.38%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.89x
- Recent ROE (-4.12%) is below the historical average (2.37%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 13.83% | 8.84% | 0.99x | 1.57x | $2.29 Million |
| 2017 | 15.36% | 10.20% | 1.00x | 1.51x | $3.64 Million |
| 2018 | 24.96% | 17.16% | 1.01x | 1.44x | $13.03 Million |
| 2019 | 13.87% | 11.57% | 0.75x | 1.60x | $3.48 Million |
| 2020 | 4.88% | 6.05% | 0.48x | 1.69x | $-5.96 Million |
| 2021 | -4.35% | -4.19% | 0.57x | 1.83x | $-15.89 Million |
| 2022 | -12.50% | -11.51% | 0.59x | 1.83x | $-24.05 Million |
| 2023 | -11.49% | -10.35% | 0.60x | 1.84x | $-20.59 Million |
| 2024 | -16.72% | -13.45% | 0.64x | 1.96x | $-21.22 Million |
| 2025 | -4.12% | -3.38% | 0.64x | 1.89x | $-10.85 Million |
Industry Comparison
This section compares Dr. Hönle AG's net assets metrics with peer companies in the Electrical Equipment & Parts industry.
Industry Context
- Industry: Electrical Equipment & Parts
- Average net assets among peers: $315,233,876
- Average return on equity (ROE) among peers: -5.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dr. Hönle AG (DRHNF) | $77.03 Million | 13.83% | 0.89x | $233.46 Million |
| ABB Ltd (ABBNY) | $2.23 Billion | -31.00% | 13.51x | $85.22 Billion |
| Advent Technologies Holdings Inc (ADN) | $130.20 Million | -15.76% | 0.25x | $1.02 Million |
| Ads Tec Energy PLC (ADSE) | $-8.59 Million | 0.00% | 0.00x | $194.80 Million |
| Advanced Energy Industries Inc (AEIS) | $392.07 Million | 32.51% | 0.46x | $11.51 Billion |
| AFC Energy plc (AFGYF) | $30.27 Million | -57.55% | 0.21x | $91.15 Million |
| Alfen N.V (ALFNF) | $6.81 Million | 25.29% | 3.39x | $265.32 Million |
| Amprius Technologies Inc. (AMPX) | $13.86 Million | -71.41% | 0.34x | $1.30 Billion |
| Asia Pacific Wire & Cable Corp Ltd (APWC) | $118.20 Million | 3.47% | 0.76x | $17.88 Million |
| Astro Communications Inc (ASTO) | $7.59 Million | 3.65% | 0.08x | $18.93K |
| Atkore International Group Inc (ATKR) | $232.94 Million | 59.69% | 5.17x | $1.72 Billion |